Relx Plc $RELX Holdings Boosted by Vise Technologies Inc.

Vise Technologies Inc. grew its stake in shares of Relx Plc (NYSE:RELX) by 25.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 75,333 shares of the technology company’s stock after buying an additional 15,063 shares during the period. Vise Technologies Inc.’s holdings in Relx were worth $2,500,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Whipplewood Advisors LLC lifted its stake in Relx by 2,468.4% in the 1st quarter. Whipplewood Advisors LLC now owns 976 shares of the technology company’s stock worth $32,000 after purchasing an additional 938 shares in the last quarter. V Square Quantitative Management LLC purchased a new position in Relx during the first quarter worth about $44,000. First Horizon Corp grew its holdings in shares of Relx by 41.0% during the first quarter. First Horizon Corp now owns 1,352 shares of the technology company’s stock worth $45,000 after purchasing an additional 393 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of Relx during the second quarter worth about $77,000. Finally, Axiom Investment Management LLC purchased a new stake in Relx in the first quarter valued at approximately $100,000. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Relx Stock Performance

NYSE RELX opened at $41.44 on Friday. The company has a debt-to-equity ratio of 5.23, a quick ratio of 0.40 and a current ratio of 0.45. Relx Plc has a 12 month low of $27.57 and a 12 month high of $43.49. The company’s 50 day moving average is $36.27 and its two-hundred day moving average is $34.52.

Analyst Upgrades and Downgrades

RELX has been the subject of a number of recent research reports. Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research report on Sunday, September 13th. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Relx in a research report on Tuesday, August 11th. Barclays reaffirmed an “overweight” rating on shares of Relx in a research report on Friday, July 24th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Relx in a research note on Friday, July 24th. Finally, Citigroup downgraded shares of Relx from a “buy” rating to a “neutral” rating in a research note on Tuesday, October 20th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Relx currently has a consensus rating of “Moderate Buy”.

Relx Profile

RELX PLC is a global information-based analytics and decision tools company serving professional and business customers. The company provides data, software, research, and workflow solutions that help organizations make decisions, manage risk, improve productivity, and access specialized knowledge.

Its main business areas include scientific, technical, and medical information; risk and business analytics; legal information and technology; and industry-focused events. Products and services include research platforms such as ScienceDirect and Scopus, legal research and workflow solutions offered through LexisNexis, and risk-management, fraud-prevention, and identity solutions provided through LexisNexis Risk Solutions.

RELX serves customers internationally, including universities, researchers, law firms, government agencies, insurers, financial institutions, corporations, and healthcare professionals.